drug design

Darren Zhu has conducted research in a wide range of cutting-edge areas, from molecular spintronics fabrication to therapeutic drug design.

Among them, the antitumor activity is the most attractive, making it as a lead compound for anticancer drug design and development.

Protein models are also used for phasing of crystallographic data and, in some cases, for drug design.

Scientists in the US have used a new drug design strategy to remove the cardiac side-effects of a popular cancer drug.

finally, the applications of insertion and deletion variation in molecular evolution, genotyping, and drug design were discussed.

Meanwhile, the developments and applications of CADD techniques accelerate the efficiency of drug design greatly.

The structures of drug-target complexes obtained by X-ray crystallography provide direct and convictive evidences for drug design.

Then it systematically examines the various families of receptors involved in human disease and drug design.

Moreover, this system can be used in drug design and find new leading compound discovery.

and for courses in drug design and drug delivery for students of medicinal chemistry.

AIM: To discuss the definition, representation and criterion of drug design defects in products liability.

These shapes determine a protein's chemical and physical properties, so knowing them can aid drug design, among other things.

CADD separates into two general categories: Mechanism-Based Drug Design and Structure-Based Drug Design.

To use C-DA method in SAR research provides new idea for predicting unknown compounds in computer aided drug design.

Nowadays the in silico scenario for drug design is totally dependent on structural biology and structural bioinformatics.

This article reviews the drug target's discovery, drug design based on targets, as well as prospects in developing novel drug.

Knowledge of the excited-state conformations of proteins may offer new opportunities for drug design.

The present copy of the journal Current Computer-Aided Drug Design (CCADD) is the inaugural issue of the journal.

Methods for protein simulations and drug design.

The study was funded by the Center for Drug Design, Academic Health Center and the National Institutes of Health.

The research of MMP inhibitors is an active field of drug design.

Chapter 2 summarized the principle of computer-aided drug design CADD.

The peptidomimetics in drug design has been reviewed in the paper.

Molecular docking is to study the interaction between the ligand and the receptor and plays a important role in rational drug design.

High-Throughout Protein Crystallization and Its Application to Drug Design

Dynamic Combinatorial Chemistry and Its Applications in Drug Design

Molecular Recognition Through Anticancer Drug Design

Pharmacophore Perception, Development, and Use in Drug Design

Applications of Bioinformatics in Computer-aided Drug Design

Protein Crystallography in Structure-Based Drug Design

Provincial Key Laboratory of New Drug Design and Evaluation

Applications of Genetic Algorithms to Computer-Aided Drug Design

Application of computer aids drug screening in new drug design and development

Computer simulator and molecular modeling for drug design;

Structure-Guided Drug Design Rediscovering the Importance of Drug Structure for Drug Discovery

The computer aided direct molecular drug design

Drug Metabolism in Drug Design and Development

The Development of Research on Calculation Methods Used in the Model-Creation of Computer-Aided Drug Design

Molecular Modeling Method in Drug Design

Recent Developments in De Novo Drug Design Method

The organic chemistry of drug design and drug action

MSc Drug Design and Biomedical Science

Guide to Computer-Assisted Drug Design

Principles of drug design and action

The Multiple Ligands and Drug Design

How to Give Prominence to Rational Drug Design in Medicinal Chemistry

Drug Design Based on Computational Protein Science

Rational Drug Design Based on Protein Structure

The Progress of Drug Design